"204-bed Hospital, 24-hour Emergency Room, Women's and Children's Services, Neuro-Stroke Services, Orthopedic Services, Bariatric Surgery, Outpatient and Inpatient Physical Therapy and Rehabilitation Services, Magnet-designated Nursing Program"

During the past decade, Bon Secours Saint Francis Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 18 clinical trials were completed, i.e. on average, 78.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 16 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bon Secours Saint Francis Hospital" #1 sponsor was "SWOG Cancer Research Network" with 12 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Academic and Community Cancer Research United" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bon Secours Saint Francis Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Bon Secours Saint Francis Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage II Breast Cancer" (3 trials), "Breast Cancer" (2 trials) and "Breast Carcinoma" (2 trials). Many other conditions were trialed in "Bon Secours Saint Francis Hospital" in a lesser frequency.

Most popular intervention types in "Bon Secours Saint Francis Hospital" are "Drug" (25 trials), "Other" (23 trials), "Biological" (10 trials), "Procedure" (7 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (8 trials), "Computed Tomography" (4 trials), "Docetaxel" (4 trials) and "Nivolumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Bon Secours Saint Francis Hospital" are 25 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bon Secours Saint Francis Hospital". undefined are not yet recruiting, 5 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Bon Secours Saint Francis Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bon Secours Saint Francis Hospital, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".